PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Abstract
PD pathway blockade elicits durable antitumor responses in a subset of patients with a broad spectrum of cancers.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Mar 02, 2016
- Source ID
- 10.1126/scitranslmed.aad7118
Entities
People
- Jedd D. Wolchok
- Lieping Chen
- Weiping Zou
Organizations
- Harry J. Lloyd Charitable Trust
- Memorial Sloan Kettering Cancer Center
- National Institutes of Health
- Ovarian Cancer Research Alliance
- Stand Up to Cancer
- United States Department of Defense
- University of Michigan
- Yale University